Human umbilical cord mesenchymal stromal cells as an adjunct therapy with therapeutic hypothermia in a piglet model of perinatal asphyxia
Autor: | Xenia Charalambous, Tatenda Mutshiya, Kathryn A. Martinello, B. Weil, Mariya Hristova, Boris W. Kramer, Ingran Lingam, Mark W. Lowdell, Tiziana Boggini, Qin Yang, Nicola J. Robertson, Adnan Avdic-Belltheus, Alan Bainbridge, Christopher Meehan, Magdalena Sokolska, Xavier Golay |
---|---|
Přispěvatelé: | RS: GROW - R4 - Reproductive and Perinatal Medicine, RS: MHeNs - R3 - Neuroscience, Kindergeneeskunde, MUMC+: MA Medische Staf Kindergeneeskunde (9) |
Rok vydání: | 2020 |
Předmět: |
CEREBRAL ENERGY FAILURE
0301 basic medicine Cancer Research Swine INFANTS Umbilical cord Umbilical Cord chemistry.chemical_compound 0302 clinical medicine Hypothermia Induced Immunology and Allergy Hippocampus (mythology) BRAIN Genetics (clinical) TUNEL assay Full-Length Article ENCEPHALOPATHY BIRTH ASPHYXIA medicine.anatomical_structure Oncology 030220 oncology & carcinogenesis GROWTH HYPOXIA-ISCHEMIA medicine.symptom STEM-CELLS STROKE medicine.medical_specialty Immunology Phosphocreatine 03 medical and health sciences Asphyxia Internal medicine Translational Research medicine Animals Humans Transplantation business.industry Mesenchymal Stem Cells Cell Biology Hypothermia medicine.disease Perinatal asphyxia Disease Models Animal 030104 developmental biology Endocrinology chemistry Terminal deoxynucleotidyl transferase Animals Newborn business |
Zdroj: | Cytotherapy Cytotherapy, 23(6), 521-535. ELSEVIER SCI LTD |
ISSN: | 1477-2566 1465-3249 |
Popis: | Background: With therapeutic hypothermia (HT) for neonatal encephalopathy, disability rates are reduced, but not all babies benefit. Pre-clinical rodent studies suggest mesenchymal stromal cells (MSCs) augment HT protection. Aims: The authors studied the efficacy of intravenous (IV) or intranasal (IN) human umbilical cord derived MSCs (huMSCs) as adjunct therapy to HT in a piglet model. Methods: A total of 17 newborn piglets underwent transient cerebral hypoxia-ischemia (HI) and were then randomized to (i) HT at 33.5 degrees C 1-13 h after HI (n = 7), (ii) HT+IV huMSCs (30 x 10(6) cells) at 24 h and 48 h after HI (n = 5) or (iii) HT+IN huMSCs (30 x 10(6) cells) at 24 h and 48 h after HI (n = 5). Phosphorus-31 and hydrogen-1 magnetic resonance spectroscopy (MRS) was performed at 30 h and 72 h and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL)-positive cells and oligodendrocytes quantified. In two further piglets, 30 x 10(6) IN PKH-labeled huMSCs were administered. Results: HI severity was similar between groups. Amplitude-integrated electroencephalogram (aEEG) recovery was more rapid for HT+IN huMSCs compared with HT from 25 h to 42 h and 49 h to 54 h (P |
Databáze: | OpenAIRE |
Externí odkaz: |